Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q3 2025 · 10-Q
Revenue$47.96M$47.96M−6.7% vs Q3 2024 Net Income$8.19M$8.19M−23.5% vs Q3 2024 EPS Diluted$0.22$0.22−33.3% vs Q3 2024 Operating Income$8,267,000−32.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$13,573,000−3.1% Margins · derivedOperating margin17.2%−6.5 pt vs Q3 2024
Net margin17.1%−3.8 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 7, 2025 · 38 d after period end